Hiroaki Yanagimoto

5.2k total citations
164 papers, 2.4k citations indexed

About

Hiroaki Yanagimoto is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroaki Yanagimoto has authored 164 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Oncology, 93 papers in Surgery and 66 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroaki Yanagimoto's work include Pancreatic and Hepatic Oncology Research (95 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (39 papers) and Gallbladder and Bile Duct Disorders (34 papers). Hiroaki Yanagimoto is often cited by papers focused on Pancreatic and Hepatic Oncology Research (95 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (39 papers) and Gallbladder and Bile Duct Disorders (34 papers). Hiroaki Yanagimoto collaborates with scholars based in Japan, United States and Russia. Hiroaki Yanagimoto's co-authors include Sohei Satoi, Hideyoshi Toyokawa, Tomohisa Yamamoto, A‐Hon Kwon, Yoichi Matsui, So Yamaki, Satoshi Hirooka, Soichiro Takai, Masanori Kon and Kanji Takahashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Hiroaki Yanagimoto

152 papers receiving 2.3k citations

Peers

Countries citing papers authored by Hiroaki Yanagimoto

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Yanagimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Yanagimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Yanagimoto more than expected).

Fields of papers citing papers by Hiroaki Yanagimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Yanagimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Yanagimoto. The network helps show where Hiroaki Yanagimoto may publish in the future.

Co-authorship network of co-authors of Hiroaki Yanagimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Yanagimoto. A scholar is included among the top collaborators of Hiroaki Yanagimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Yanagimoto. Hiroaki Yanagimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utility of postoperative plasma D-Dimer testing for early prediction of venous thromboembolism after pancreatectomy: A retrospective study 2025 ·Asian Journal of Surgery ·Takuya Mizumoto, Hirochika Toyama, Yoshihide Nanno, Jun Ishida, Takeshi Urade, (unknown), Hidetoshi Gon, (unknown), Shohei Komatsu, Sadaki Asari, Hiroaki Yanagimoto, Masahiro Kido, (unknown)	0
2	Treatment outcomes of hepatectomy and systemic chemotherapy based on oncological resectability criteria for hepatocellular carcinoma 2024 ·Annals of Gastroenterological Surgery ·Shohei Komatsu, Yoshihiko Yano, (unknown), Masahiro Kido, Hidetoshi Gon, (unknown), Takeshi Urade, Hiroaki Yanagimoto, (unknown), Takumi Fukumoto	1
3	Assessment of the biliary branching pattern of the caudate lobe in perihilar cholangiocarcinoma using ENBD‐CT cholangiography 2024 ·Journal of Hepato-Biliary-Pancreatic Sciences ·Masayuki Akita, Hiroaki Yanagimoto, Daisuke Tsugawa, Keitaro Sofue, Hidetoshi Gon, Shohei Komatsu, (unknown), (unknown), Tetsuo Ajiki, (unknown)	1
4	Preoperative level of serum transthyretin as a novel biomarker predicting survival in resected pancreatic ductal adenocarcinoma with neoadjuvant therapy 2024 ·Pancreatology ·Yoshihide Nanno, Hirochika Toyama, Takuya Mizumoto, Jun Ishida, Takeshi Urade, (unknown), Hidetoshi Gon, (unknown), (unknown), Sadaki Asari, Hiroaki Yanagimoto, Masahiro Kido, (unknown)	2
5	Adjuvant S-1 vs. observation for resected biliary tract cancer: 5-year follow-up of the JCOG1202/ASCOT. 2024 ·Journal of Clinical Oncology ·Kohei Nakachi, Masafumi Ikeda, Masaru Konishi, Junki Mizusawa, Hiroshi Katayama, (unknown), Katsuhiko Uesaka, Hiroaki Yanagimoto, Soichiro Morinaga, Hiroshi Wada, Kazuaki Shimada, Yu Takahashi, (unknown), Kunihito Gotoh, Ken Kamata, Yasuhiro Shimizu, Hiroshi Ishii, Takuji Okusaka, Junji Furuse, Makoto Ueno	1
6	Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma 2024 ·Hepatology Research ·(unknown), Shohei Komatsu, Keitaro Sofue, Eisuke Ueshima, (unknown), (unknown), Jun Ishida, Masahiro Kido, Hidetoshi Gon, (unknown), Takeshi Urade, Hiroaki Yanagimoto, Hirochika Toyama, Yoshihide Ueda, Yuzo Kodama, Takamichi Murakami, Takumi Fukumoto	5
7	Prognostic Impact of Malnutrition Diagnosed by the GLIM Criteria for Resected Extrahepatic Cholangiocarcinoma 2023 ·Anticancer Research ·(unknown), Hiroaki Yanagimoto, Daisuke Tsugawa, Masayuki Akita, (unknown), (unknown), Takeshi Urade, Yoshihide Nanno, (unknown), Hidetoshi Gon, Shohei Komatsu, Kaori Kuramitsu, Tadahiro Goto, Sadaki Asari, Hirochika Toyama, Masahiro Kido, (unknown), (unknown)	2
8	Factors Predicting Over-Time Weight Increase After Liver Transplantation: A Retrospective Study 2023 ·Transplantation Proceedings ·(unknown), Kaori Kuramitsu, Masahiro Kido, Shohei Komatsu, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, (unknown), Toshihiko Yoshida, (unknown), Daisuke Tsugawa, Tadahiro Goto, Sadaki Asari, Hiroaki Yanagimoto, Hirochika Toyama, Tetsuo Ajiki, Takumi Fukumoto	0
9	Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202 2023 ·European Journal of Surgical Oncology ·Shogo Kobayashi, (unknown), Masafumi Ikeda, Masaru Konishi, Gakuto Ogawa, Teiichi Sugiura, Hiroaki Yanagimoto, Soichiro Morinaga, Hiroshi Wada, Kazuaki Shimada, Yu Takahashi, Toshio Nakagohri, Ken Kamata, Yasuhiro Shimizu, Tetsuo Ajiki, Satoshi Hirano, Naoto Gotohda, Makoto Ueno, Takuji Okusaka, Junji Furuse	3
10	Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study 2022 ·Journal of Hepato-Biliary-Pancreatic Sciences ·Shohei Komatsu, Kazuomi Ueshima, Masahiro Kido, Kaori Kuramitsu, Daisuke Tsugawa, Hiroaki Yanagimoto, Hirochika Toyama, (unknown), Masatoshi Kudo, Takumi Fukumoto	8
11	Space-Making Particle Therapy for Unresectable Hilar Cholangiocarcinoma 2022 ·Digestive Surgery ·(unknown), Shohei Komatsu, Kazuki Terashima, Daisuke Tsugawa, Hiroaki Yanagimoto, (unknown), Yusuke Demizu, Sunao Tokumaru, Tomoaki Okimoto, Ryohei Sasaki, Tetsuo Ajiki, Takumi Fukumoto	4
12	Use of a short cartridge stapler is beneficial in pancreatic transection at the neck during laparoscopic distal pancreatectomy 2022 ·Surgery Today ·Jun Ishida, Hirochika Toyama, Sadaki Asari, Tadahiro Goto, Yoshihide Nanno, Takuya Mizumoto, Daisuke Tsugawa, Shohei Komatsu, Kaori Kuramitsu, Hiroaki Yanagimoto, Masahiro Kido, Takumi Fukumoto	1
13	Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma 2020 ·Cancers ·Hiroaki Yanagimoto, Sohei Satoi, Tomohisa Yamamoto, So Yamaki, Satoshi Hirooka, (unknown), Hironori Ryota, Mitsuaki Ishida, Yoichi Matsui, Mitsugu Sekimoto	13
14	Does modified Blumgart anastomosis without intra-pancreatic ductal stenting reduce post-operative pancreatic fistula after pancreaticojejunostomy? 2018 ·Asian Journal of Surgery ·Sohei Satoi, Tomohisa Yamamoto, Hiroaki Yanagimoto, So Yamaki, Hisashi Kosaka, Satoshi Hirooka, (unknown), Hironori Ryota, Taku Michiura, Kentaro Inoue, Yoichi Matsui	19
15	Pancreaticogastrostomy as an additional procedure following distal pancreatectomy can preventpost-operative pancreatic fistula-related complication 2013 ·Hironori Ryota, Sohei Satoi, Hiroaki Yanagimoto, Hideyoshi Toyokawa, Tomohisa Yamamoto, Satoshi Hirooka, Rintaro Yui, So Yamaki, Taku Michiura, Kentaro Inoue, Yoichi Matsui, A‐Hon Kwon	0
16	Clinical Effects of Neoadjuvant Chemoradiation Therapy Using S-1 for Patients with Pancreatic Cancer 2012 ·Sohei Satoi, Hideyoshi Toyokawa, Hiroaki Yanagimoto, Tomohisa Yamamoto, Satoshi Hirooka, So Yamaki, Taku Michiura, Kentaro Inoue, Yoichi Matsui, A‐Hon Kwon	0
17	Neo-adjuvant Chemoradiation Therapy Using S-1 Followed by Surgical Resection in Patients with Pancreatic Cancer 2011 ·Journal of Gastrointestinal Surgery ·Sohei Satoi, Hideyoshi Toyokawa, Hiroaki Yanagimoto, Tomohisa Yamamoto, Minoru Kamata, Chisato Ohe, Noriko Sakaida, Yoshiko Uemura, Hiroaki Kitade, Noboru Tanigawa, Kentaro Inoue, Yoichi Matsui, A‐Hon Kwon	31
18	Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer 2009 ·Suizo ·Sohei Satoi, Hiroaki Yanagimoto, Hideyoshi Toyokawa, Kanji Takahashi, Yoichi Matsui, Hiroaki Kitade, Hynek Mergental, Noboru Tanigawa, Soichiro Takai, A‐Hon Kwon	2
19	The Annual Changes and Clinicopathologic Features of Cholangiocellular Carcinoma in Patients with Hepatitis C Virus in the Kansai Medical University Hospital 2004 ·The Japanese Journal of Gastroenterological Surgery ·N. Terakawa, Sohei Satoi, Hiroaki Yanagimoto, Hidekazu Yamamoto, Tomohisa Yamamoto, Soichiro Takai, A‐Hon Kwon, Shin Yamamoto, Yoshitsugu Kubota, Yasuo Kamiyama	1
20	Impaired function of circulating dendritic cells in patients with pancreatic cancer 2004 ·Clinical Immunology ·Hiroaki Yanagimoto, Soichiro Takai, Sohei Satoi, Hideyoshi Toyokawa, Kanji Takahashi, N. Terakawa, A‐Hon Kwon, Yasuo Kamiyama	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact